[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.98.119. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1955

Piperazine in the Treatment of Enterobiasis

Author Affiliations

From the Department of Pediatrics, 1600th U.S.A.F. Hospital, Westover Air Force Base, Mass.

AMA Am J Dis Child. 1955;89(3):346-349. doi:10.1001/archpedi.1955.02050110412013
Abstract

Enterobiasis is the most common helminth infestation in the United States. The pinworm has proved to be a difficult parasite to eradicate for the human race. Although reports of therapeutic agents have filled the medical literature throughout the years, not one drug has been universally accepted. Cram1 gave the following criteria for a satisfactory agent:

  1. The drug must be highly effective in removing pinworms.

  2. The drug must be relatively nontoxic, so that it can be given in repeated treatments over a period during which viable pinworm ova may be present in the patient's surroundings, the repeated administration of the drug also assuring its entrance into the cecum and appendix, common sites of pinworm infection.

  3. The treatment must be of such reasonable cost that its use in large families will not be prohibitive.

  4. The treatment must be so easily administered that it can be used with

First Page Preview View Large
First page PDF preview
First page PDF preview
×